Skip to content

Effect of prophylactic analgesia of iliacia block with liposomal bupivacaine on perioperative neurocognitive impairment and quality of recovery in elderly patients with hip fracture

Effect of prophylactic analgesia of iliacia block with liposomal bupivacaine on perioperative neurocognitive impairment and quality of recovery in elderly patients with hip fracture

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600121580
Enrollment
Unknown
Registered
2026-04-01
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture

Interventions

Bupivacaine liposomal group:Iliofascial block using bupivacaine liposomes
Ropivacaine group:Iliofascial block with ropivacaine

Sponsors

Lishui peoples hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Age:60-90 years; 2.BMI:19-28kg/m^²; 3.Patients undergoing elective unilateral THA surgery; 4.ASA grade: I, II, III;

Exclusion criteria

Exclusion criteria: 1.communication barriers; 2.Preoperative cognitive impairment; 3.Contraindications to deep nerve block, including but not limited to anesthetic drug allergy, coagulation disorders (INR > 1.5 and/or platelet count <70×10^9), injection site infection; 4.Chronic opioid dependence or chronic pain for more than 3 months; 5.Patients with mental illness (including depression, schizophrenia, epilepsy, Parkinson's disease, or Alzheimer's disease) or patients who cannot cooperate in completing the rating scale; 6.Combined with severe heart, lung, liver or kidney dysfunction, such as liver decompensation (Child B/C grade), etc. 7.Other surgeries within 6 months prior to admission; 8.Nerve blocks cannot be performed due to anatomical difficulties in ultrasound scanning;

Design outcomes

Primary

MeasureTime frame
Incidence of neurocognitive impairment at 7 days, 1 month, and 12 months after surgery;

Secondary

MeasureTime frame
Remedial analgesia;Postoperative hospital stay;Incidence of postoperative delirium (POD) within 7 days after surgery;Cumulative consumption of opioids at 24 and 48 hours after surgery;Time to first get out of bed after surgery;Recovery of quality on the 1st, 2nd, and 3rd postoperative days (QoR-15);Resting and active NRS scores at 2, 4, 8, 24, and 48h after surgery;

Countries

China

Contacts

Public ContactWu Jimim

Lishui peoples hospital

wujimin2022@163.com+86 5751234567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026